Journal articles on the topic 'Factor VIII (FVIII)'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Factor VIII (FVIII).'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Yada, Koji, Kenichi Ogiwara, Masaru Shibata, Midori Shima, and Keiji Nogami. "Effects of anti-factor VIII inhibitor antibodies on factor VIIa/tissue factor-catalysed activation and inactivation of factor VIII." Thrombosis and Haemostasis 105, no. 06 (2011): 989–98. http://dx.doi.org/10.1160/th10-12-0781.
Yada, Koji, Keiji Nogami, Kenichi Ogiwara, Katsumi Nishiya, Masahiro Takeyama, and Midori Shim. "Effects of Anti-FVIII Inhibitors On Factor VIIa/Tissue Factor-Catalyzed Activation and Inactivation of Factor VIII." Blood 114, no. 22 (November 20, 2009): 3169. http://dx.doi.org/10.1182/blood.v114.22.3169.3169.
Nakajima, Yuto, Koji Yada, Keiji Nogami, and Midori Shima. "A Novel Mechanism of Factor VIIa/Tissue Factor (TF)-Catalyzed Activation and Inactivation of B-Domain-Deleted Factor VIII in the Early Initiation Phases of Coagulation." Blood 132, Supplement 1 (November 29, 2018): 1162. http://dx.doi.org/10.1182/blood-2018-99-115645.
Ogiwara, Kenichi, Keiji Nogami, Masahiro Okuda, Katsumi Nishiya, Masahiro Takeyama, and Midori Shima. "Interactions of Factor VIII with Tissue Factor Contributes to the Acceleration of Factor Xa Generation in the Initiation Phase of Blood Coagulation." Blood 114, no. 22 (November 20, 2009): 3177. http://dx.doi.org/10.1182/blood.v114.22.3177.3177.
Ogiwara, Kenichi, Keiji Nogami, Tetsuhiro Soeda, Tomoko Matsumoto, Katsumi Nishiya, and Midori Shima. "Mechanisms of Factor VIII Activation by Recombinant Factor VIIa Analog through Tissue Factor-Independent Manner." Blood 112, no. 11 (November 16, 2008): 1028. http://dx.doi.org/10.1182/blood.v112.11.1028.1028.
Meeks, Shannon, Ernest T. Parker, Amy L. Dunn, John F. Healey, and Pete Lollar. "Proteolytically Inactivatable Factor VIII is Less Immunogenic than Factor VIII in a Murine Hemophilia A Model." Blood 114, no. 22 (November 20, 2009): 27. http://dx.doi.org/10.1182/blood.v114.22.27.27.
Soeda, Tetsuhiro, Keiji Nogami, Tomoko Matsumoto, Kenichi Ogiwara, Katsumi Nishiya, and Midori Shima. "Tissue Factor-Dependent Activation of Factor VIII by Factor VIIa in the Early Phase of Blood Coagulation." Blood 112, no. 11 (November 16, 2008): 1036. http://dx.doi.org/10.1182/blood.v112.11.1036.1036.
Messer, Amanda S., Barbara Ulmasov, Yogesh Kumar, Kanagasabai Vadivel, Degang Zhong, Philip Fay, and S. Paul Bajaj. "Epitope Mapping of a Monoclonal Antibody to Factor VIII That Inhibits Factor IXa:Factor VIIIa Interaction and Thrombin Activation of Factor VIII." Blood 118, no. 21 (November 18, 2011): 1177. http://dx.doi.org/10.1182/blood.v118.21.1177.1177.
Zakas, Philip, Kristopher Knight, Ernest T. Parker, H. Trent Spencer, Eric Gaucher, and Christopher B. Doering. "Bioengineering Coagulation Factor VIII through Ancestral Protein Reconstruction." Blood 126, no. 23 (December 3, 2015): 123. http://dx.doi.org/10.1182/blood.v126.23.123.123.
Radtke, Klaus-Peter, Dean Chamberlain, John H. Griffin, and Andrew J. Gale. "Whole Blood Thromboelastogram Assays Demonstrate Prolonged Factor VIIIa Potency for Recombinant Disulfide Bond-Stabilized Factor VIII Variants." Blood 104, no. 11 (November 16, 2004): 2976. http://dx.doi.org/10.1182/blood.v104.11.2976.2976.
Ogiwara, Kenichi, Midori Shima, and Keiji Nogami. "Factor VIII activation by factor VIIa analog (V158D/E296V/M298Q) in tissue factor-independent mechanisms." Thrombosis and Haemostasis 106, no. 10 (2011): 665–74. http://dx.doi.org/10.1160/th11-04-0264.
Takeyama, Masahiro, Keiji Nogami, Tomoko Matsumoto, Tetsuhiro Soeda, Tsukasa Suzuki, Kunihiro Hattori, and Midori Shima. "Characterisation of an antibody specific for coagulation factor VIII that enhances factor VIII activity." Thrombosis and Haemostasis 103, no. 01 (2010): 94–102. http://dx.doi.org/10.1160/th09-05-0338.
Shoko, Furukawa, Keiji Nogami, Kenichi Ogiwara, and Midori Shima. "Mechanism of Tissue Factor (TF) Enhancing Factor (F)VIII Activity on FXa Generation in Initial Phase of Coagulation and Interaction Between TF and FVIII C2 Domain." Blood 128, no. 22 (December 2, 2016): 1391. http://dx.doi.org/10.1182/blood.v128.22.1391.1391.
Wilhelm, Amelia R., Nicole A. Parsons, Benjamin J. Samelson-Jones, Robert J. Davidson, Charles T. Esmon, Rodney M. Camire, and Lindsey A. George. "Activated protein C has a regulatory role in factor VIII function." Blood 137, no. 18 (May 6, 2021): 2532–43. http://dx.doi.org/10.1182/blood.2020007562.
Rozenshteyn, Diana, and Andrew J. Gale. "Cathepsin G, a leukocyte protease, activates coagulation factor VIII." Thrombosis and Haemostasis 99, no. 01 (2008): 44–51. http://dx.doi.org/10.1160/th07-08-0495.
Hausl, Christina, Rafi U. Ahmad, Maria Sasgary, Christopher B. Doering, Pete Lollar, Günter Richter, Hans Peter Schwarz, Peter L. Turecek, and Birgit M. Reipert. "High-dose factor VIII inhibits factor VIII–specific memory B cells in hemophilia A with factor VIII inhibitors." Blood 106, no. 10 (November 15, 2005): 3415–22. http://dx.doi.org/10.1182/blood-2005-03-1182.
Doshi, Bhavya, Courtney Cox, Bagirath Gangadharan, Christopher B. Doering, and Shannon L. Meeks. "Factor VIII Supplementation Improves Recombinant VIIa Initiated Thrombin Generation in Hemophilia A Inhibitor Patient Plasmas." Blood 118, no. 21 (November 18, 2011): 28. http://dx.doi.org/10.1182/blood.v118.21.28.28.
Zhong, Degang, Evgueni L. Saenko, Midori Shima, Matthew Felch, and Dorothea Scandella. "Some Human Inhibitor Antibodies Interfere With Factor VIII Binding to Factor IX." Blood 92, no. 1 (July 1, 1998): 136–42. http://dx.doi.org/10.1182/blood.v92.1.136.413k35_136_142.
Ponder, Katherine P. "FIXing Factor VIII inhibitors." Blood 119, no. 2 (January 12, 2012): 325–26. http://dx.doi.org/10.1182/blood-2011-11-389486.
Peerlinck, Kathelijne, Marc G. Jacquemin, Jef Arnout, Marc F. Hoylaerts, Jean Guy G. Gilles, Renaud Lavend’homme, Karen M. Johnson, et al. "Antifactor VIII Antibody Inhibiting Allogeneic but not Autologous Factor VIII in Patients With Mild Hemophilia A." Blood 93, no. 7 (April 1, 1999): 2267–73. http://dx.doi.org/10.1182/blood.v93.7.2267.
Peerlinck, Kathelijne, Marc G. Jacquemin, Jef Arnout, Marc F. Hoylaerts, Jean Guy G. Gilles, Renaud Lavend’homme, Karen M. Johnson, et al. "Antifactor VIII Antibody Inhibiting Allogeneic but not Autologous Factor VIII in Patients With Mild Hemophilia A." Blood 93, no. 7 (April 1, 1999): 2267–73. http://dx.doi.org/10.1182/blood.v93.7.2267.407k21_2267_2273.
Takeyama, Masahiro, Keiji Nogami, Tetsuhiro Soeda, Tsukasa Suzuki, Kunihiro Hattori, Kohei Tatsumi, Yuri Fujita, Ichiro Tanaka, Akira Yoshioka, and Midori Shima. "Characterization of an Anti-Factor VIII Monoclonal Antibody with A1 and A3 Epitopes Which Increases Factor VIII Activity." Blood 108, no. 11 (November 16, 2006): 1702. http://dx.doi.org/10.1182/blood.v108.11.1702.1702.
Gale, Andrew J., Diana Rozenshteyn, and Justin Riceberg. "The Neutrophil Proteases, Elastase and Cathepsin G, May Modulate the Activity of Factor VIII." Blood 108, no. 11 (November 16, 2006): 1716. http://dx.doi.org/10.1182/blood.v108.11.1716.1716.
Nogami, Keiji, Katsumi Nishiya, Yoshihiko Sakurai, Ichiro Tanaka, John Giddings, Evgueni Saenko, Akira Yoshioka, and Midori Shima. "Human Factor VIII Inhibitor Alloantibodies with a C2 Epitope Inhibit Factor Xa-catalyzed Factor VIII Activation: A new Anti-factor VIII Inhibitory Mechanism." Thrombosis and Haemostasis 87, no. 03 (2002): 459–65. http://dx.doi.org/10.1055/s-0037-1613026.
Okayama, Yusuke, Masato Bingo, Kazuki Sakatoku, Hiroshi Okamura, Satoru Nanno, Mitsutaka Nishimoto, Yasuhiro Nakashima, Hideo Koh, Masayuki Hino, and Hirohisa Nakamae. "The safety of the combination therapy of recombinant factor VIIa and plasma-derived factor VIIa and factor X for refractory hemorrhage in acquired hemophilia A." Blood Coagulation & Fibrinolysis 34, no. 6 (July 19, 2023): 419–22. http://dx.doi.org/10.1097/mbc.0000000000001243.
Takeyama, Masahiro, Keiji Nogami, Tomoko Matsumoto, and Midori Shima. "Factor VIII A2 Domain Contains a Binding Site for Factor X." Blood 124, no. 21 (December 6, 2014): 4226. http://dx.doi.org/10.1182/blood.v124.21.4226.4226.
Neuenschwander, Pierre F. "Evidence of Abnormal Coagulation: Production of Factor VIII α-Fragment In Vivo." Blood 106, no. 11 (November 16, 2005): 1020. http://dx.doi.org/10.1182/blood.v106.11.1020.1020.
York, Elizabeth S., Jasmine Ito, and Glaivy Batsuli. "Investigating persistent factor VIII-specific IgM in the humoral immune response to factor VIII." Journal of Immunology 210, no. 1_Supplement (May 1, 2023): 229.12. http://dx.doi.org/10.4049/jimmunol.210.supp.229.12.
Yada, Koji, Keiji Nogami, Kenichi Ogiwara, and Midori Shima. "A novel mechanism of Enhancing the Haemostatic Effect in the Combination with Recombinant Factor VIII and Activated Prothrombin Complex Concentrate(APCC) in Hemophilia A Patients with Inhibitor." Blood 118, no. 21 (November 18, 2011): 1178. http://dx.doi.org/10.1182/blood.v118.21.1178.1178.
Hsu, Ting-Chang, Kathleen P. Pratt, and Arthur R. Thompson. "The factor VIII C1 domain contributes to platelet binding." Blood 111, no. 1 (January 1, 2008): 200–208. http://dx.doi.org/10.1182/blood-2007-01-068957.
Grushin, Kirill, Jaimy Miller, Daniela Dalm, and Svetla Stoilova-McPhie. "Factor VIII organisation on nanodiscs with different lipid composition." Thrombosis and Haemostasis 113, no. 04 (July 2015): 741–49. http://dx.doi.org/10.1160/th14-09-0725.
Russell, Joshua, Yesim Dargaud, Randal J. Kaufman, Claude Negrier, and Steven W. Pipe. "Inactivation-Resistant Recombinant Factor VIII Exhibits Superior Thrombin Generation Capacity in Comparison to Wild-Type and B Domain-Deleted Factor VIII." Blood 108, no. 11 (November 16, 2006): 1604. http://dx.doi.org/10.1182/blood.v108.11.1604.1604.
Foster, PA, CA Fulcher, RA Houghten, and TS Zimmerman. "Synthetic factor VIII peptides with amino acid sequences contained within the C2 domain of factor VIII inhibit factor VIII binding to phosphatidylserine." Blood 75, no. 10 (May 15, 1990): 1999–2004. http://dx.doi.org/10.1182/blood.v75.10.1999.bloodjournal75101999.
Healey, John F., Ernest Parker, and John (Pete) S. Lollar. "Comparative Decay Rates of Human, Rhesus Macaque, Cynomolgus, and Porcine Activated Factor VIII." Blood 114, no. 22 (November 20, 2009): 3164. http://dx.doi.org/10.1182/blood.v114.22.3164.3164.
Novakovic, Valerie A., David B. Cullinan, Hironao Wakabayashi, Philip J. Fay, James D. Baleja, and Gary E. Gilbert. "Membrane-binding properties of the Factor VIII C2 domain." Biochemical Journal 435, no. 1 (March 15, 2011): 187–96. http://dx.doi.org/10.1042/bj20101797.
Foster, PA, CA Fulcher, RA Houghten, and TS Zimmerman. "Synthetic factor VIII peptides with amino acid sequences contained within the C2 domain of factor VIII inhibit factor VIII binding to phosphatidylserine." Blood 75, no. 10 (May 15, 1990): 1999–2004. http://dx.doi.org/10.1182/blood.v75.10.1999.1999.
Livnat, Tami, Amy L. Dunn, Shirley Azar-Avivi, Wallace Hunter Baldwin, Gili Kenet, and Shannon L. Meeks. "Epitope Specific Discrepancies Between Antibody Mediated Inhibition Of Recombinant Factor VIII and Plasma Derived Factor VIII Containing Von Willebrand Factor Affecting All Domains Of Factor VIII." Blood 122, no. 21 (November 15, 2013): 1089. http://dx.doi.org/10.1182/blood.v122.21.1089.1089.
Lannert, Kerry W., Hilary S. Gammill, Barbara A. Konkle, and Jill M. Johnsen. "The Ability of Von Willebrand Factor (VWF) to Bind Factor VIII (FVIII) Can Decrease during Pregnancy." Blood 124, no. 21 (December 6, 2014): 4244. http://dx.doi.org/10.1182/blood.v124.21.4244.4244.
Gangadharan, Bagirath, H. Trent Spencer, Ernest T. Parker, and Christopher B. Doering. "High-Level Expression of Porcine Factor VIII from Murine Mesenchymal Stem Cells." Blood 104, no. 11 (November 16, 2004): 5281. http://dx.doi.org/10.1182/blood.v104.11.5281.5281.
Minami, Hiroaki, Keiji Nogami, Takehisa Kitazawa, Kunihiro Hattori, and Midori Shima. "FVIII Heavy Chain Enhances Tenase Activity Induced By FVIIIa Mimicking Bispesific Antibody, ACE910." Blood 124, no. 21 (December 6, 2014): 1481. http://dx.doi.org/10.1182/blood.v124.21.1481.1481.
Novakovic, Valerie A., James D. Baleja, and Gary E. Gilbert. "The Factor VIIII C2 Domain Shows Stereospecificity for Phosphatidyl-L-Serine and Increases Factor IXa Activity." Blood 112, no. 11 (November 16, 2008): 3090. http://dx.doi.org/10.1182/blood.v112.11.3090.3090.
Rolli, Veronique, Nathalie Enjolras, Cecile Ducasse, Marie-Helene Rodriguez, Thomas Weimer, Hans-Peter Hauser, Claude Negrier, and Jean-Luc Plantier. "Generation of Factor VIII Molecules Partially Resistant to Activated Protein C." Blood 104, no. 11 (November 16, 2004): 1729. http://dx.doi.org/10.1182/blood.v104.11.1729.1729.
Markovitz, Rebecca C., John F. Healey, W. Hunter Baldwin, Ernest T. Parker, Shannon L. Meeks, and Pete Lollar. "Decreasing the Humoral Response to Factor VIII By Targeted Deletion of Factor VIII - Specific B Cells." Blood 124, no. 21 (December 6, 2014): 238. http://dx.doi.org/10.1182/blood.v124.21.238.238.
Mazurier, Claudine, Armelle Parquet-Gernez, and Maurice Goudemand. "Validation of a Procedure for Potency Assessing of a High Purity Factor VIII Concentrate -Comparison of Different Factor VIII Coagulant Assays and Effect of Prediluent." Thrombosis and Haemostasis 64, no. 02 (1990): 251–55. http://dx.doi.org/10.1055/s-0038-1647295.
Planque, Stephanie, Miguel A. Escobar, Hiroaki Taguchi, Sangeeta Karle, Yasuhiro Nishiyama, Elizabeth Donnachie, and Sudhir Paul. "Irreversible Blockade of Factor VIII Antibodies." Blood 104, no. 11 (November 16, 2004): 1728. http://dx.doi.org/10.1182/blood.v104.11.1728.1728.
Fu, Richard, Meghan J. Lyle, Xuefeng Wang, and Carol H. Miao. "Factor VIII-specific CAR regulatory T cells modulate murine anti-factor VIII immune responses." Journal of Immunology 196, no. 1_Supplement (May 1, 2016): 126.13. http://dx.doi.org/10.4049/jimmunol.196.supp.126.13.
Hausl, Christina, Rafi U. Ahmad, Maria Sasgary, Christopher B. Doering, Pete S. Lollar, Guenter Richter, Hans Peter Schwarz, Peter L. Turecek, and Birgit M. Reipert. "Inhibition of Factor VIII-Specific Memory B Cell Responses by Supra-Physiological Concentrations of Factor VIII." Blood 104, no. 11 (November 16, 2004): 38. http://dx.doi.org/10.1182/blood.v104.11.38.38.
Mertens, Koen, David Gestel, Gunny van Stempvoort, Vincent Limburg, Ed E. Moret, and Alexander B. Meijer. "Somatic Mutations in Factor VIII Inhibitors Determine Their Factor VIII Binding and Inhibitory Properties." Blood 110, no. 11 (November 16, 2007): 1762. http://dx.doi.org/10.1182/blood.v110.11.1762.1762.
Tang, Liang, Clark Pan, Harpartap Atwal, Jennifer Nixon, Thomas Barnett, John E. Murphy, Baisong Mei, and Michael Fournel. "PEGylation of Factor VIII Reduces the Inhibitory Effects of Human Antibody Inhibitors on the Factor VIII Molecule." Blood 108, no. 11 (November 16, 2006): 4017. http://dx.doi.org/10.1182/blood.v108.11.4017.4017.
Nogami, Keiji, Midori Shima, Tomoko Matsumoto, Katsumi Nishiya, Masahiro Takeyama, Kohei Tatsumi, Ichiro Tanaka, and Akira Yoshioka. "Mechanisms of Plasmin-Catalyzed Inactivation of the Factor VIII." Blood 106, no. 11 (November 16, 2005): 1017. http://dx.doi.org/10.1182/blood.v106.11.1017.1017.